ITP: A historical perspective

British Journal of Haematology

Volumn 153, Issue 4, 2011, Pages 437-450

  Stasi, Roberto ^a   Newland, Adrian C ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antiplatelet antibodies; Immune thrombocytopenia; Purpura; Thrombocytopenia; Thrombopoietin

Indexed keywords

ALEMTUZUMAB; AUTOANTIBODY; CORTICOSTEROID; CORTICOTROPIN; ELTROMBOPAG; FIBRIN; FOSTAMATINIB; GLYCOPROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GMA 161; MONOCLONAL ANTIBODY MDX 33; PREDNISOLONE; RHESUS D ANTIBODY; RITUXIMAB; ROMIPLOSTIM; THROMBOPOIETIN; UNCLASSIFIED DRUG;

BLEEDING; CD8+ T LYMPHOCYTE; CELL MATURATION; CYTOTOXIC T LYMPHOCYTE; DRUG ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG RESPONSE; EXERCISE; EXPERIMENTAL STUDY; HELPER CELL; HEMOSTASIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPATHOGENESIS; MEGAKARYOCYTE; NONHUMAN; PHLEBOTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PURPURA; REGULATORY T LYMPHOCYTE; REVIEW; SPLENECTOMY; SURGICAL MORTALITY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

AUTOANTIBODIES; BLOOD PLATELETS; HEMATOLOGY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; PORTRAITS AS TOPIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; T-LYMPHOCYTE SUBSETS;

EID: 79955038881     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08562.x     Document Type: Review

References (139)

1. Altman, L.K. (1998) Who Goes First? The Story of Self-Experimentation in Medicine. University of California Press, Berkeley and Los Angeles, California, USA.
2. Ballem, P.J., Segal, G.M., Stratton, J.R., Gernsheimer, T., Adamson, J.W. & Slichter, S.J. (1987) Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. Journal of Clinical Investigation, 80, 33-40.
3. Bartley, T.D., Bogenberger, J., Hunt, P., Li, Y.S., Lu, H.S., Martin, F., Chang, M.S., Samal, B., Nichol, J.L., Swift, S., Johnson, M.J., Hsu, R.-Y., Parker, V.P., Suggs, S., Skrine, J.D., Merewether, L.A., Clogston, C., Hsu, E., Hokom, M.M., Hornkohl, A., Choi, E., Pangelinan, M., Sun, Y., Mar, V., McNinch, J., Simonet, L., Jacobsen, F., Xie, C., Shutter, J., Chute, H., Basu, R., Selander, L., Trollinger, D., Sieu, L., Padilla, D., Trail, G., Elliott, G., Izumi, R., Covey, T., Crouse, J., Garcia, A., Xu, W., Del Castillo, J., Biron, J., Cole, S., Hu, M.C.-T., Pacifici, R., Ponting, I., Saris, C., Wen, D., Yung, Y.P., Lin, H. & Rosselman, R.A. (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell, 77, 1117-1124.
4. Bizzozero, G. (1882) Ueber einen neuen Forrnbestandteil des Blutes und dessen Rolle bei der Thrombose und Blutgerinnung. Virchows Archiv fur Pathologische Anatomie und Physiologie und fur Klinische Medizin, 90, 261-332.
5. Blanchette, M. & Freedman, J. (1998) The history of idiopathic thrombocytopenic purpura (ITP). Transfusion Science, 19, 231-236.
6. Branehog, I., Kutti, J. & Weinfeld, A. (1974) Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP). British Journal of Haematology, 27, 127-143.
7. Brohm, F. (1883) Quoted by Krauss, E. Über purpura. Inaugural dissertation. Heidelberg, 1883.
8. Bussel, J.B., Graziano, J.N., Kimberly, R.P., Pahwa, S. & Aledort, L.M. (1991) Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood, 77, 1884-1893.
9. Bussel, J.B., Provan, D., Shamsi, T., Cheng, G., Psaila, B., Kovaleva, L., Salama, A., Jenkins, J.M., Roychowdhury, D., Mayer, B., Stone, N. & Arning, M. (2009a) Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet, 373, 641-648.
10. Bussel, J.B., Kuter, D.J., Pullarkat, V., Lyons, R.M., Guo, M. & Nichol, J.L. (2009b) Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood, 113, 2161-2171.
11. Chang, M., Nakagawa, P.A., Williams, S.A., Schwartz, M.R., Imfeld, K.L., Buzby, J.S. & Nugent, D.J. (2003) Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood, 102, 887-895.
12. Cheng, G., Saleh, M.N., Marcher, C., Vasey, S., Mayer, B., Aivado, M., Arning, M., Stone, N.L. & Bussel, J.B. (2010) Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet. E-pub ahead of print. doi:
13. Clarkson, S.B., Bussel, J.B., Kimberly, R.P., Valinsky, J.E., Nachman, R.L. & Unkeless, J.C. (1986) Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. New England Journal of Medicine, 314, 1236-1239.
14. Cooper, N. & Bussel, J. (2006) The pathogenesis of immune thrombocytopaenic purpura. British Journal of Haematology, 133, 364-374.
15. Cooper, N., Woloski, B.M., Fodero, E.M., Novoa, M., Leber, M., Beer, J.H. & Bussel, J.B. (2002) Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? Blood, 99, 1922-1927.
16. Cronkite, E.P. (1944) Further studies of platelet-reducing substances in splenic extracts. Annals of Internal Medicine, 20, 52-62.
17. Dameshek, W. & Miller, E.B. (1946) The megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenism. Blood, 1, 27-51.
18. Denys, H. (1887) Etudes sur la coagulation du sang dans un cas de purpura avec diminution conside'rable des plaquettes. La Cellule, 3, 445-462.
19. Dixon, R., Rosse, W. & Ebbert, L. (1975) Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response. New England Journal of Medicine, 292, 230-236.
20. Duke, W.W. (1912) The behavior of the blood platelets in toxemias and haemorrhagic disease: A preliminary report. Bulletin of The Johns Hopkins Hospital, 23, 144.
21. Ehrlich, P. (1879) Methodologische Beiträge zur Physiologie und Pathologie der verschiedenen Formen der Leukocyten. Zeitschrift fur Klinische Medizin, 1, 553-560.
22. Eliason, E.L. & Ferguson, L.K. (1932) Splenectomy in Purpura Hemorrhagica. Annals of Surgery, 96, 801-829.
23. Emmerich, F., Bal, G., Barakat, A., Milz, J., Muhle, C., Martinez-Gamboa, L., Dorner, T. & Salama, A. (2007) High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. British Journal of Haematology, 136, 309-314.
24. Emmons, R.V., Reid, D.M., Cohen, R.L., Meng, G., Young, N.S., Dunbar, C.E. & Shulman, N.R. (1996) Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood, 87, 4068-4071.
25. Evans, R.S., Takahashi, K., Duane, R.T., Payne, R. & Liu, C. (1951) Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Archives of Internal Medicine, 87, 48-65.
26. Filion, M.C., Bradley, A.J., Devine, D.V., Decary, F. & Chartrand, P. (1995) Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal anergy. European Journal of Immunology, 25, 3123-3127.
27. Fogarty, P.F., Rick, M.E., Zeng, W., Risitano, A.M., Dunbar, C.E. & Bussel, J.B. (2003) T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy. Clinical and Experimental Immunology, 133, 461-466.
28. Frank, E. (1915) Die essentielle thrombopenie (Konstitutionelle Purpura-Pseudohämophilie), I: Klinische Bild. Berliner klinische Wochenschrift, 52, 454-458.
29. Frederiksen, H. & Schmidt, K. (1999) The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood, 94, 909-913.
30. Garnock-Jones, K.P. & Keam, S.J. (2009) Eltrombopag. Drugs, 69, 567-576.
31. Harker, L.A. (1970) Thrombokinetics in idiopathic thrombocytopenic purpura. British Journal of Haematology, 19, 95-104.
32. Harker, L.A. & Finch, C.A. (1969) Thrombokinetics in man. Journal of Clinical Investigation, 48, 963-974.
33. Harrington, W.J., Minnich, V., Hollingsworth, J.W. & Moore, C.V. (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. Journal of Laboratory and Clinical Medicine, 38, 1-10.
34. Hayem, G. (1889) Du Sang et de ses Alterations Anatomiques. G Masson, Paris.
35. Henoch, E. (1899) Vorlesungen über Kinderkrankheiten. 10th edn. (ed. by A. Hirschwald ), August Hirschwald, Berlin.
36. Heyns, A.d.P., Badenhorst, P.N., Lotter, M.G., Pieters, H., Wessels, P. & Kotze, H.F. (1986) Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ. Blood, 67, 86-92.
37. Hobson, F.C.G. & Witts, L.J. (1940) Platelet-reducing extracts of the spleen. British Medical Journal, 4123, 50-51.
38. Houwerzijl, E.J., Blom, N.R., van der Want, J.J., Esselink, M.T., Koornstra, J.J., Smit, J.W., Louwes, H., Vellenga, E. & de Wolf, J.T. (2004) Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood, 103, 500-506.
39. Howell, W.H. (1890) Observations upon the occurrence, structure, and function of the giant cells of the marrow. Journal of Morphology, 4, 117-130.
40. Imbach, P., Barandun, S., d'Apuzzo, V., Baumgartner, C., Hirt, A., Morell, A., Rossi, E., Schoni, M., Vest, M. & Wagner, H.P. (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet, 1, 1228-1231.
41. Imbach, P., Kuhne, T. & Signer, E. (2002) Historical aspects and present knowledge of idiopathic thrombocytopenic purpura. British Journal of Haematology, 119, 894-900.
42. Jones, H.W. & Tocantins, L.M. (1933) The history of purpura hemorrhagica. Annals of Medical History, 5, 349-359.
43. Kane, I., Ragucci, D., Shatat, I.F., Bussel, J. & Kalpatthi, R. (2010) Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura. British Journal of Haematology, 149, 79-83.
44. Kaznelson, P. (1916) Verschwinden der hämorrhagischen Diathese bei einem Falle von ''essentieller Thrombopenie'' (Frank) nach Milzexstirpation: splenogene thrombolytische Purpura. Wiener Klinische Wochenschrift, 29, 1451-1454.
45. Kaznelson, P. (1919) Thrombolytische Purpura. Zeitschrift fur Klinische Medizin, 87, 133-164.
46. Kiefel, V., Santoso, S., Weisheit, M. & Mueller-Eckhardt, C. (1987) Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood, 70, 1722-1726.
47. Kojouri, K., Vesely, S.K., Terrell, D.R. & George, J.N. (2004) Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood, 104, 2623-2634.
48. Kosugi, S., Kurata, Y., Tomiyama, Y., Tahara, T., Kato, T., Tadokoro, S., Shiraga, M., Honda, S., Kanakura, Y. & Matsuzawa, Y. (1996) Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. British Journal of Haematology, 93, 704-706.
49. Kuter, D.J. & Gernsheimer, T.B. (2009) Thrombopoietin and platelet production in chronic immune thrombocytopenia. Hematology/Oncology Clinics of North America, 23, 1193-1211.
50. Kuter, D.J., Beeler, D.L. & Rosenberg, R.D. (1994) The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proceedings of the National Academy of Sciences of the United States of America, 91, 11104-11108.
51. Kuter, D.J., Bussel, J.B., Lyons, R.M., Pullarkat, V., Gernsheimer, T.B., Senecal, F.M., Aledort, L.M., George, J.N., Kessler, C.M., Sanz, M.A., Liebman, H.A., Slovick, F.T., de Wolf, J.T., Bourgeois, E., Guthrie, Jr, T.H., Newland, A., Wasser, J.S., Hamburg, S.I., Grande, C., Lefrere, F., Lichtin, A.E., Tarantino, M.D., Terebelo, H.R., Viallard, J.F., Cuevas, F.J., Go, R.S., Henry, D.H., Redner, R.L., Rice, L., Schipperus, M.R., Guo, D.M. & Nichol, J.L. (2008) Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet, 371, 395-403.
52. Kuter, D.J., Rummel, M., Boccia, R., Macik, B.G., Pabinger, I., Selleslag, D., Rodeghiero, F., Chong, B.H., Wang, X. & Berger, D.P. (2010) Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia. New England Journal of Medicine, 363, 1889-1899.
53. Kuwana, M., Kaburaki, J. & Ikeda, Y. (1998) Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. Journal of Clinical Investigation, 102, 1393-1402.
54. Kuwana, M., Kaburaki, J., Kitasato, H., Kato, M., Kawai, S., Kawakami, Y. & Ikeda, Y. (2001) Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood, 98, 130-139.
55. Lazarus, A.H. & Crow, A.R. (2003) Mechanism of action of IVIG and anti-D in ITP. Transfusion and Apheresis Science, 28, 249-255.
56. Ledingham, J.C.G. (1914) The experimental production of purpura in animals by the introduction of anti-blood-plate sera: a preliminary communication. Lancet, 183, 1673-1676.
57. van Leeuwen, E.F., van der Ven, J.T., Engelfriet, C.P. & von dem Borne, A.E. (1982) Specificity of autoantibodies in autoimmune thrombocytopenia. Blood, 59, 23-26.
58. Li, X. & Hou, M. (2008) Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opinion on Emerging Drugs, 13, 237-254.
59. + T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura. British Journal of Haematology, 139, 605-611.
60. Lim, S.H., Hale, G., Marcus, R.E., Waldmann, H. & Baglin, T.P. (1993) CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura. British Journal of Haematology, 84, 542-544.
61. Lok, S., Kaushansky, K., Holly, R.D., Kuijper, J.L., Lofton-Day, C.E., Oort, P.J., Grant, F.J., Heipel, M.D., Burkhead, S.K., Kramer, J.M., Bell, L.A., Sprecher, C.A., Blumberg, H., Johnson, R., Prunkard, D., Ching, A.F.T., Mathewes, S.L., Bailey, M.C., Forstrom, J.W., Buddle, M.M., Osborn, S.G., Evans, S.J., Sheppard, P.O., Presnell, S.R., O' Hara, P.J., Hagen, F.S., Roth, G.J. & Foster, D.C. (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature, 369, 565-568.
62. Lusitanus, A. (1556) Curationum medicinalum Centuriae quatuor. Froben, Basileae.
63. Marino, F. (1905) Recherches sur les plaquettes du sang. Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales, 58, 194-196.
64. Mathias, S.D., Gao, S.K., Miller, K.L., Cella, D., Snyder, C., Turner, R., Wu, A., Bussel, J.B., George, J.N., McMillan, R., Wysocki, D.K. & Nichol, J.L. (2008) Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health and Quality of Life Outcomes, 6, 13.
65. McMillan, R. & Durette, C. (2004) Long-term outcomes in adults with chronic ITP after splenectomy failure. Blood, 104, 956-960.
66. McMillan, R., Luiken, G.A., Levy, R., Yelenosky, R. & Longmire, R.L. (1978) Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA, 239, 2460-2462.
67. McMillan, R., Tani, P., Millard, F., Berchtold, P., Renshaw, L. & Woods, Jr, V.L. (1987) Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood, 70, 1040-1045.
68. McMillan, R., Wang, L., Tomer, A., Nichol, J. & Pistillo, J. (2004) Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood, 103, 1364-1369.
69. McMillan, R., Bussel, J.B., George, J.N., Lalla, D. & Nichol, J.L. (2008) Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. American Journal of Hematology, 83, 150-154.
70. Michel, M., Novoa, M.V. & Bussel, J.B. (2003) Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy. British Journal of Haematology, 123, 142-146.
71. Molineux, G. & Newland, A. (2010) Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside. British Journal of Haematology, 150, 9-20.
72. Newland, A.C., Treleaven, J.G., Minchinton, R.M. & Waters, A.H. (1983) High-dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet, 1, 84-87.
73. Newland, A.C., Boots, M.A. & Patterson, K.G. (1984) Intravenous IgG for autoimmune thrombocytopenia in pregnancy. New England Journal of Medicine, 310, 261-262.
74. Newman, G.C., Novoa, M.V., Fodero, E.M., Lesser, M.L., Woloski, B.M. & Bussel, J.B. (2001) A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura. British Journal of Haematology, 112, 1076-1078.
75. Neylon, A.J., Saunders, P.W., Howard, M.R., Proctor, S.J. & Taylor, P.R. (2003) Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. British Journal of Haematology, 122, 966-974.
76. Nugent, D., McMillan, R., Nichol, J.L. & Slichter, S.J. (2009) Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. British Journal of Haematology, 146, 585-596.
77. Olsson, B., Andersson, P.O., Jernas, M., Jacobsson, S., Carlsson, B., Carlsson, L.M. & Wadenvik, H. (2003) T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nature Medicine, 9, 1123-1124.
78. Osler, W. (1874) An account of certain organisms occurring in the liquor sanguinis. Proceedings of the Royal Society of London, 22, 391-398.
79. Otanasek, F. & Lee, F.C. (1941) Further observations on thrombocytopen. Journal of Laboratory and Clinical Medicine, 26, 1266-1273.
80. Patel, V.L., Schwartz, J. & Bussel, J.B. (2008) The effect of anti-CD40 ligand in immune thrombocytopenic purpura. British Journal of Haematology, 141, 545-548.
81. Paul, J.T. (1942) Effect of splenic extracts from cases of essential thrombopenic purpura upon platelets and hematopoietic organs of rabbits. Journal of Laboratory and Clinical Medicine, 27, 754-762.
82. + regulatory T cells and SOCS3-mediated suppression of Treg function. European Journal of Immunology, 37, 2082-2089.
83. Pisciotta, A.V., Stefanini, M. & Dameshek, W. (1953) Studies on platelets X. Morphologic characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura. Blood, 8, 703-723.
84. Podolanczuk, A., Lazarus, A.H., Crow, A.R., Grossbard, E. & Bussel, J.B. (2009) Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk. Blood, 113, 3154-3160.
85. Portielje, J.E., Westendorp, R.G., Kluin-Nelemans, H.C. & Brand, A. (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood, 97, 2549-2554.
86. Provan, D. & Newland, A. (2002) Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults. British Journal of Haematology, 118, 933-944.
87. Provan, D., Stasi, R., Newland, A.C., Blanchette, V.S., Bolton-Maggs, P., Bussel, J.B., Chong, B.H., Cines, D.B., Gernsheimer, T.B., Godeau, B., Grainger, J., Greer, I., Hunt, B.J., Imbach, P.A., Lyons, G., McMillan, R., Rodeghiero, F., Sanz, M.A., Tarantino, M., Watson, S., Young, J. & Kuter, D.J. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115, 168-186.
88. Psaila, B. & Bussel, J.B. (2008) Refractory immune thrombocytopenic purpura: current strategies for investigation and management. British Journal of Haematology, 143, 16-26.
89. Qureshi, A.H., Chaoji, V., Maiguel, D., Faridi, M.H., Barth, C.J., Salem, S.M., Singhal, M., Stoub, D., Krastins, B., Ogihara, M., Zaki, M.J. & Gupta, V. (2009) Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling. PLoS ONE, 4, e7627.
90. Rabellino, E.M., Levene, R.B., Leung, L.L. & Nachman, R.L. (1981) Human megakaryocytes II. Expression of platelet proteins in early marrow megakaryocytes. Journal of Experimental Medicine, 154, 88-100.
91. Riverius, L. (1668) On pestilential feavers. In: The practice of physick (ed. by Culpepper N.), p. 618. Streator, London.
92. Robb-Smith, A.H. (1967) Why the platelets were discovered. British Journal of Haematology, 13, 618-637.
93. Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D.M., Bussel, J.B., Cines, D.B., Chong, B.H., Cooper, N., Godeau, B., Lechner, K., Mazzucconi, M.G., McMillan, R., Sanz, M.A., Imbach, P., Blanchette, V., Kuhne, T., Ruggeri, M. & George, J.N. (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 113, 2386-2393.
94. Rolleston, H. (1934) The history of hæmatology. Proceedings of the Royal Society of Medicine, 27, 1161-1178.
95. Rose, H.J. & Boyer, L.B. (1941) Thrombocytopen: a confirmatory report. Journal of Clinical Investigation, 20, 81-86.
96. Salama, A., Mueller-Eckhardt, C. & Kiefel, V. (1983) Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet, 2, 193-195.
97. Saleh, M.N., Gutheil, J., Moore, M., Bunch, P.W., Butler, J., Kunkel, L., Grillo-Lopez, A.J. & LoBuglio, A.F. (2000) A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia. Seminars in Oncology, 27, 99-103.
98. Saleh, M.N., Bussel, J.B., Cheng, G., Meddeb, B., Mayer, B., Bailey, C. & Aivado, M. (2009) Long-Term Treatment of Chronic Immune Thrombocytopenic Purpura with Oral Eltrombopag: Results From the EXTEND Study. Blood (ASH Annual Meeting Abstracts), 114, 682.
99. Sarpatwari, A., Watson, S., Erqou, S., Anderson, H., Grainger, J., Higgins, J.P. & Newland, A.C. (2010a) Heath-related lifestyle in adults and children with primary immune thrombocytopenia (ITP). British Journal of Haematology, 151, 189-191.
100. Sarpatwari, A., Bennett, D., Logie, J.W., Shukla, A., Beach, K.J., Newland, A.C., Sanderson, S. & Provan, D. (2010b) Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database. Haematologica, 95, 1167-1175.
101. Satoh, T., Pandey, J.P., Okazaki, Y., Asahi, A., Kawakami, Y., Ikeda, Y. & Kuwana, M. (2009) Single nucleotide polymorphism of interleukin-1beta associated with Helicobacter pylori infection in immune thrombocytopenic purpura. Tissue Antigens, 73, 353-357.
102. de Sauvage, F.J., Hass, P.E., Spencer, S.D., Malloy, B.E., Gurney, A.L., Spencer, S.A., Darbonne, W.C., Henzel, W.J., Wong, S.C., Kuang, W.J., Oles, K.J., Hultgren, B., Solberg, Jr, L.A., Goeddel, D.V. & Eaton, D.L. (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature, 369, 533-538.
103. Scaradavou, A., Woo, B., Woloski, B.M., Cunningham-Rundles, S., Ettinger, L.J., Aledort, L.M. & Bussel, J.B. (1997) Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood, 89, 2689-2700.
104. Schoonen, W.M., Kucera, G., Coalson, J., Li, L., Rutstein, M., Mowat, F., Fryzek, J. & Kaye, J.A. (2009) Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. British Journal of Haematology, 145, 235-244.
105. Schultze, M. (1865) Ein heizbarer Objecttisch und seineVerwendung bei Untersuchungen des Blutes. Archiv für mikroscopische Anatomie, 1, 1-14.
106. Semple, J.W. & Freedman, J. (1994) Natural killer cell numbers and activity in patients with chronic autoimmune thrombocytopenic purpura. Blood, 83, 870-871.
107. Semple, J.W., Bruce, S. & Freedman, J. (1991) Suppressed natural killer cell activity in patients with chronic autoimmune thrombocytopenic purpura. American Journal of Hematology, 37, 258-262.
108. Semple, J.W., Milev, Y., Cosgrave, D., Mody, M., Hornstein, A., Blanchette, V. & Freedman, J. (1996) Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood, 87, 4245-4254.
109. Shimomura, T., Fujimura, K., Takafuta, T., Fujii, T., Katsutani, S., Noda, M., Fujimoto, T. & Kuramoto, A. (1996) Oligoclonal accumulation of T cells in peripheral blood from patients with idiopathic thrombocytopenic purpura. British Journal of Haematology, 95, 732-737.
110. Shulman, N.R., Marder, V.J. & Weinrach, R.S. (1965) Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies. Annals of the New York Academy of Sciences, 124, 499-542.
111. Smith, E. (1886) A practical treatise on disease in children. William Wood & Company, New York.
112. Spence, A.W. (1928) The results of splenectomy for purpura hæmorrhagica. British Journal of Surgery, 15, 466-499.
113. Stahl, C.P., Zucker-Franklin, D. & McDonald, T.P. (1986) Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP. Blood, 67, 421-428.
114. Stasi, R., Pagano, A., Stipa, E. & Amadori, S. (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood, 98, 952-957.
115. Stasi, R., Del Poeta, G., Stipa, E., Evangelista, M.L., Trawinska, M.M., Cooper, N. & Amadori, S. (2007) Response to B-cell depleting therapy with rituximab reverts the abnormalities of T cell subsets in patients with idiopathic thrombocytopenic purpura. Blood, 110, 2924-2930.
116. Stasi, R., Evangelista, M.L., Stipa, E., Buccisano, F., Venditti, A. & Amadori, S. (2008a) Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thrombosis and Haemostasis, 99, 4-13.
117. Stasi, R., Cooper, N., Del Poeta, G., Stipa, E., Laura Evangelista, M., Abruzzese, E. & Amadori, S. (2008b) Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood, 112, 1147-1150.
118. Stasi, R., Willis, F., Shannon, M.S. & Gordon-Smith, E.C. (2009a) Infectious causes of chronic immune thrombocytopenia. Hematology/Oncology Clinics of North America, 23, 1275-1297.
119. Stasi, R., Sarpatwari, A., Segal, J.B., Osborn, J., Evangelista, M.L., Cooper, N., Provan, D., Newland, A., Amadori, S. & Bussel, J.B. (2009b) Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood, 113, 1231-1240.
120. Stoll, D., Cines, D.B., Aster, R.H. & Murphy, S. (1985) Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood, 65, 584-588.
121. Suzuki, T., Matsushima, M., Shirakura, K., Koike, J., Masui, A., Takagi, A., Shirasugi, Y., Ogawa, Y., Shirai, T. & Mine, T. (2008) Association of inflammatory cytokine gene polymorphisms with platelet recovery in idiopathic thrombocytopenic purpura patients after the eradication of Helicobacter pylori. Digestion, 77, 73-78.
122. Thakur, M.L., Welch, M.J., Joist, J.H. & Coleman, R.E. (1976) Indium-111 labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thrombosis Research, 9, 345-357.
123. Tidy, L. (1928) The haemorrhagic diathesis. Proceedings of the Royal Society of Medicine, 21, 1033-1052.
124. Troland, C.E. & Lee, F.C. (1938) Thrombocytopen, a substance in the extract from the spleen of patients with idiopathic thrombocytopenic purpura that reduces the number of blood platelets. Journal of the American Medical Association, 111, 221-226.
125. Uihlein, A. (1942) Effect of Injection of tissue extracts on the number of blood platelets. Journal of Laboratory and Clinical Medicine, 28, 157-167.
126. Vesely, S.K., Perdue, J.J., Rizvi, M.A., Terrell, D.R. & George, J.N. (2004) Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Annals of Internal Medicine, 140, 112-120.
127. Vinci, G., Tabilio, A., Deschamps, J.F., Van Haeke, D., Henri, A., Guichard, J., Tetteroo, P., Lansdorp, P.M., Hercend, T., Vainchenker, W. & Breton-Gorius, J. (1984) Immunological study of in vitro maturation of human megakaryocytes. British Journal of Haematology, 56, 589-605.
128. Werlhof, P.G. (1735) Disquisitio medica et philologica de variolis et anthracibus, signis differentiis, medelis disserit etc. Nicolai Foersteri, Hannover.
129. Whipple, A.O. (1926) Splenectomy as a therapeutic measure in thrombocytopenic purpura haemorrhagica. Surgery, Gynecology & Obstetrics, 42, 329-341.
130. Willan, R. (1808) On cutaneous diseases. J. Jonson, London.
131. Willis, F., Marsh, J.C., Bevan, D.H., Killick, S.B., Lucas, G., Griffiths, R., Ouwehand, W., Hale, G., Waldmann, H. & Gordon-Smith, E.C. (2001) The effect of treatment with Campath-1H in patients with autoimmune cytopenias. British Journal of Haematology, 114, 891-898.
132. Wintrobe, M.M., Cartwright, G.E., Palmer, J.G., Kuhns, W.J. & Samuels, L.T. (1951) Effect of corticotrophin and cortisone on the blood in various disorders in man. AMA Archives of Internal Medicine, 88, 310-336.
133. Woodforde, T. (1828) Case of purpura hæmorrhagica. The Lancet, 10, 576-576.
134. Woods, Jr, V.L., Kurata, Y., Montgomery, R.R., Tani, P., Mason, D., Oh, E.H. & McMillan, R. (1984a) Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura. Blood, 64, 156-160.
135. Woods, Jr, V.L., Oh, E.H., Mason, D. & McMillan, R. (1984b) Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood, 63, 368-375.
136. Wright, J.H. (1906) The origin and nature of blood plates. Boston Medical and Surgical Journal, 154, 643-645.
137. Yoshida, Y. (2008) The light and shadow of Paul Kaznelson: his life and contribution to hematology. Annals of Hematology, 87, 877-879.
138. Yu, J., Heck, S., Patel, V., Levan, J., Yu, Y., Bussel, J.B. & Yazdanbakhsh, K. (2008) Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood, 112, 1325-1328.
139. Zhao, H., Du, W., Wang, D., Gu, D., Xue, F., Ge, J., Sui, T. & Yang, R. (2010) Single nucleotide polymorphism in the methyl-CpG binding domain 4 gene and the risk for immune thrombocytopenic purpura in Chinese population. Platelets, 21, 132-136.